Antinuclear Antibodies: A Marker Associated with Steroid Dependence in Patients with Ulcerative Colitis

被引:20
|
作者
Barahona-Garrido, J. [1 ]
Camacho-Escobedo, J. [1 ]
Garcia-Martinez, C. I. [1 ]
Tocay, H. [1 ]
Cabiedes, J. [2 ]
Yamamoto-Furusho, J. K. [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Gastroenterol, Inflammatory Bowel Dis Clin, Mexico City 14000, DF, Mexico
[2] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City 14000, DF, Mexico
关键词
ulcerative colitis; antinuclear antibodies; inflammatory bowel disease; steroid dependence; extraintestinal manifestations; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; AUTOANTIBODIES; THERAPY; SERUM;
D O I
10.1002/ibd.20852
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The autoimmune phenomena and the autoantibody profile have acquired great importance in ulcerative colitis (UC). Few studies have explored antinuclear antibodies (ANAs) prevalence, but not its association with steroid dependence. We hypothesized that ANAs could be a factor associated to steroid dependence. Methods: Ninety-seven consecutive patients with UC were in. patterns were determined by indirect chided. ANA titers and staining immunofluorescence. Gender, age, follow-up time, C-reactive protein (CRP), disease extent, Mayo Score Activity Index, extraintestinal manifestations, and steroid dependence were analyzed in univariate and multivariate models. Results: Ninety-seven Patients were included and 49 (50.5%) were females mean age was 41.7 +/- 22.2),cars. Positivity for ANAs was encountered in 52 (53.5%) patients, and none for anti-dsDNA. The prevalence of ANAs was higher in steroid-dependent than in nonsteroid-dependent patients (77.8% versus 48.1%, P = 0.020: odds ratio [OR] = 3.9, 95% confidence interval [CI] 1.1-12.5), and in those with uveitis (100% versus 51.1% P = 0.040) or pyodemia gangrenosum (100% versus 51.6%: P = 0.078). No association was observed with gender, age, CRP. disease extent, and Mayo Score Activity Index. The multiple regression analysis model showed all association between steroid dependence and ANAs (P = 0.033, OR = 3.9,95% Cl 1.4-14.9). Conclusions: ANAs are associated with steroid dependence in UC patients. Further studies are required to determine the role of ANAs as serological markers for prediction of steroid dependence in order to perform early therapeutic interventions with biological agents. (Inflamm Bowel Dis 2009:15:1039-1043)
引用
收藏
页码:1039 / 1043
页数:5
相关论文
共 50 条
  • [11] Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis
    Dobric, Senka
    Popovic, Dragan
    Nikolic, Milos
    Andrejevic, Sladjana
    Spuran, Milan
    Bonaci-Nikolic, Branka
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (03) : 503 - 509
  • [12] Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution
    Diaz-Jimenez, David
    De la Fuente, Marjorie
    Dubois-Camacho, Karen
    Landskron, Glauben
    Fuentes, Janitza
    Perez, Tamara
    Julieta Gonzalez, Maria
    Simian, Daniela
    Hermoso, Marcela A.
    Quera, Rodrigo
    BMC GASTROENTEROLOGY, 2016, 16
  • [13] Pharmacotherapy in Patients with Ulcerative Colitis
    Scherer, M.
    Hardt, J.
    Blozik, E.
    Preiss, J. C.
    Bokemeyer, B.
    Hueppe, A.
    Raspe, H.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2011, 49 (07): : 820 - 826
  • [14] Oral tacrolimus for pediatric steroid-resistant ulcerative colitis
    Navas-Lopez, V. M.
    Blasco Alonso, J.
    Serrano Nieto, M. J.
    Giron Fernandez-Crehuet, F.
    Argos Rodriguez, M. D.
    Sierra Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (01): : 64 - 69
  • [15] Relationship between Ulcerative Colitis Patients Treated with Leukocytapheresis and Ulcerative Colitis-associated Colorectal Cancer
    Kinugasa, Tetsushi
    Akagi, Yoshito
    Murotani, Kenta
    Romeo, Kansakar
    Yoshida, Takefumi
    Ryu, Yasuhiko
    Shiratuchi, Ichitarou
    Shirouzu, Kazuo
    ANTICANCER RESEARCH, 2011, 31 (07) : 2547 - 2552
  • [16] Accelerated Clearance of Infliximab is Associated With Treatment Failure in Patients With Corticosteroid-Refractory Acute Ulcerative Colitis
    Kevans, David
    Murthy, Sanjay
    Mould, Diane R.
    Silverberg, Mark S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 (06): : 662 - 669
  • [17] Azathioprine is essential following cyclosporine for patients with steroid-refractory ulcerative colitis
    Miyake, Nobuyuki
    Ando, Takafumi
    Ishiguro, Kazuhiro
    Maeda, Osamu
    Watanabe, Osamu
    Hirayama, Yutaka
    Maeda, Keiko
    Morise, Kazuhiro
    Matsushita, Masanobu
    Furukawa, Kazuhiro
    Funasaka, Kohei
    Nakamura, Masanao
    Miyahara, Ryoji
    Ohmiya, Naoki
    Goto, Hidemi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (01) : 254 - 261
  • [18] Being Elderly Is Associated with Infectious and Fatal Postoperative Complications in Ulcerative Colitis Patients
    Horio, Yuki
    Uchino, Motoi
    Kusunoki, Kurando
    Minagawa, Tomohiro
    Kuwahara, Ryuichi
    Kimura, Kei
    Kataoka, Kozo
    Beppu, Naohito
    Ikeda, Masataka
    Ikeuchi, Hiroki
    DIGESTION, 2022, 103 (06) : 470 - 479
  • [19] Factors associated with disability in patients with ulcerative colitis: A cross-sectional study
    Marinelli, Carla
    Zingone, Fabiana
    Inferrera, Marco
    Lorenzon, Greta
    Rigo, Alessandra
    Facchin, Sonia
    Caccaro, Roberta
    D'Inca, Renata
    Savarino, Edoardo Vincenzo
    JOURNAL OF DIGESTIVE DISEASES, 2020, 21 (02) : 81 - 87
  • [20] Tofacitinib Is Associated With Increased Risk of Postoperative Venous Thromboembolism in Patients With Ulcerative Colitis
    Russell, Tara
    Banerjee, Sudeep
    Lipman, Jeremy
    Holubar, Stefan
    Hull, Tracy
    Steele, Scott
    Lightner, Amy
    DISEASES OF THE COLON & RECTUM, 2024, 67 (05) : 693 - 699